Yamato Holdings Co., Ltd. (Head office: Chuo-ku, Tokyo; President & CEO: Toshiyuki Sakurai) and Alfresa Holdings Corporation (Head office: Chiyoda-ku, Tokyo; President & CEO: Yusuke Fukami) established MY MEDICA Co., Ltd. (Head office: Yokohama City, Kanagawa Prefecture; President & CEO: Masaru Ito) to support health management and prevent serious illness among employees in the transportation industry. From March 25, 2026 (Wed) to June 11, 2026 (Thu), MY MEDICA conducted a survey on post-health check follow-up actions among its users. - Prior to using MY MEDICA, only 24.5% of users underwent follow-up examinations after receiving health check results. - The top reason for not undergoing follow-up exams was "too busy with work." - After using MY MEDICA, 86.2% of users reported that the barrier to seeing a doctor decreased, and 88.0% received follow-up exams within three months. ■ Background The rate of abnormal findings in periodic health checkups has been rising year by year. According to a 2024 survey, 59.4% of individuals had some form of abnormality, particularly high rates related to lifestyle diseases: blood lipids (31.2%) and blood pressure (18.4%). (Source: Ministry of Health, Labour and Welfare, "Periodic Health Checkup Results Report") For companies, early lifestyle improvements and medical interventions for those with abnormal findings are critical to securing workforce and reducing healthcare costs. MY MEDICA Co., Ltd. provides "MY MEDICA," an online healthcare and wellness service that enables users to consult doctors during spare time, supporting prevention of disease progression for individuals who have been flagged in health screenings but remain untreated or undiagnosed. Against this backdrop, MY MEDICA conducted a survey targeting 690 users who underwent follow-up exams via the MY MEDICA platform to assess post-health checkup care. Survey Period: March 25, 2026 (Wed) – June 11, 2026 (Thu) Survey Target: Users who underwent follow-up exams via MY MED